HMG-CoA Reductase Inhibitor class drugs

16 results
  • atorvastatin calcium

    (Atorvastatin calcium)
    NIVAGEN PHARMACEUTICALS, INC.
    Atorvastatin calcium is indicated to reduce the risk of myocardial infarction, stroke, and angina in at-risk adults. It also lowers LDL cholesterol in adults with hyperlipidemia, heterozygous or homozygous familial hypercholesterolemia, and treats primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet.
  • caduet

    (amlodipine besylate and atorvastatin calcium)
    Pfizer Laboratories Div Pfizer Inc
    CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.
  • crestor

    (Rosuvastatin)
    AstraZeneca Pharmaceuticals LP
    CRESTOR is indicated for reducing the risk of major cardiovascular events in adults at increased risk, as an adjunct to diet for lowering LDL cholesterol in various hyperlipidemias, and for treating primary dysbetalipoproteinemia and hypertriglyceridemia in adults. It is also used in pediatric patients with familial hypercholesterolemia.
  • ezetimibe and simvastatin

    (Ezetimibe and Simvastatin)
    AvKARE
    Ezetimibe and simvastatin tablets are indicated as adjunct therapy to diet for reducing cholesterol and triglyceride levels in patients with primary or mixed hyperlipidemia, including homozygous familial hypercholesterolemia. They are part of a comprehensive approach to reduce the risk of atherosclerotic vascular disease.
  • lipitor

    (atorvastatin calcium)
    Viatris Specialty LLC
    LIPITOR is indicated to reduce the risk of myocardial infarction, stroke, and angina in adults with or without coronary heart disease risk factors. It also lowers LDL cholesterol in adults and children with primary hyperlipidemia, familial hypercholesterolemia, and other dyslipidemias as an adjunct to diet.
  • rosuvastatin calcium

    (Rosuvastatin Calcium)
    Shandong New Time Pharmaceutical Co., Ltd.
    Rosuvastatin is indicated for reducing cardiovascular risk in adults without coronary heart disease, lowering LDL-C in various hyperlipidemia types, treating familial hypercholesterolemia in children and adults, and addressing primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet and other therapies.
  • rosuvastatin calcium

    (Rosuvastatin Calcium)
    TORRENT PHARMACEUTICALS LIMITED
    Rosuvastatin is indicated to reduce the risk of major cardiovascular events in adults at increased risk, and as an adjunct to diet for lowering LDL cholesterol in various conditions, including primary hyperlipidemia, heterozygous familial hypercholesterolemia, and homozygous familial hypercholesterolemia in both adults and children.
  • rosuvastatin calcium

    (Rosuvastatin Calcium)
    Cadila Pharmaceuticals Limited
    Rosuvastatin tablets are indicated for reducing cardiovascular disease risk in adults, managing hyperlipidemia, and treating familial hypercholesterolemia in patients aged 7 and older. They also help reduce LDL-C and slow atherosclerosis progression, and are used alongside diet and other therapies for cholesterol control.
  • rosuvastatin calcium

    (Rosuvastatin Calcium)
    Ascend Laboratories, LLC
    Rosuvastatin tablets are indicated to reduce cardiovascular risks in adults at increased risk, lower LDL-C in those with primary hyperlipidemia, and treat heterozygous or homozygous familial hypercholesterolemia in pediatric and adult patients. It also aids in managing primary dysbetalipoproteinemia and hypertriglyceridemia.
  • rosuvastatin calcium

    (rosuvastatin calcium)
    Zhejiang Yongtai Pharmaceutical Co., Ltd.
    Rosuvastatin is indicated to reduce major cardiovascular events in adults at high risk, lower LDL cholesterol in adults and children with hyperlipidemia or familial hypercholesterolemia, and treat conditions like primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet.